Filter News
Area of Research
News Topics
- (-) Bioenergy (7)
- (-) Fusion (1)
- (-) Isotopes (3)
- (-) Materials (2)
- (-) Materials Science (3)
- (-) Security (1)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (10)
- Advanced Reactors (2)
- Artificial Intelligence (2)
- Biology (1)
- Biomedical (2)
- Biotechnology (1)
- Chemical Sciences (2)
- Climate Change (2)
- Composites (1)
- Computer Science (7)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (4)
- Environment (6)
- Exascale Computing (1)
- High-Performance Computing (1)
- Machine Learning (2)
- Microscopy (1)
- Molten Salt (1)
- Nanotechnology (4)
- Neutron Science (3)
- Nuclear Energy (6)
- Physics (1)
- Polymers (2)
- Quantum Science (1)
- Summit (2)
- Sustainable Energy (9)
- Transformational Challenge Reactor (2)
- Transportation (3)
Media Contacts
Scientists at ORNL used neutron scattering and supercomputing to better understand how an organic solvent and water work together to break down plant biomass, creating a pathway to significantly improve the production of renewable
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
Scientists studying a valuable, but vulnerable, species of poplar have identified the genetic mechanism responsible for the species’ inability to resist a pervasive and deadly disease. Their finding, published in the Proceedings of the National Academy of Sciences, could lead to more successful hybrid poplar varieties for increased biofuels and forestry production and protect native trees against infection.
Brixon, Inc., has exclusively licensed a multiparameter sensor technology from the Department of Energy’s Oak Ridge National Laboratory. The integrated platform uses various sensors that measure physical and environmental parameters and respond to standard security applications.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.